<div class="container">

<table style="width: 100%;"><tr>
<td>MultAdj</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Simulation-based design of traditional trials with multiple objectives
</h2>

<h3>Description</h3>

<p>This function supports power calculations for a broad class of Phase III clinical trials with multiple objectives, including
</p>

<ul>
<li>
<p> Trials with a single source of multiplicity, i.e., trials with a single endpoint and several dose-control comparisons, or two-arm trials with several endpoints.
</p>
</li>
<li>
<p> Trials with several sources of multiplicity, i.e., trials with several endpoints and several dose-placebo comparisons.
</p>
</li>
</ul>
<p>A fixed-sample design is assumed in this setting. Most commonly used multiplicity adjustments are supported for trials with a single source of multiplicity. In addition, global testing procedures can be applied in two-arm trials with several endpoints. Popular gatekeeping procedures are supported in the advanced multiplicity problems with several sources. For examples of the function call, see MultAdjExample1, MultAdjExample2 or MultAdjExample3.
</p>


<h3>Usage</h3>

<pre><code class="language-R">MultAdj(parameters)
</code></pre>


<h3>Arguments</h3>

<table><tr style="vertical-align: top;">
<td><code>parameters</code></td>
<td>
<p>List of the trial design and other parameters. The required elements are defined below: 
</p>

<ul>
<li> <p><code>endpoint_type</code>: Character value defining the common type of trial endpoints. Possible values:  
</p>

<ul>
<li> <p><code>"Normal"</code>: Normally distributed endpoint.
</p>
</li>
<li> <p><code>"Binary"</code>: Binary endpoint.
</p>
</li>
</ul>
</li>
<li> <p><code>direction</code>: Character value defining the common direction of favorable outcome for all endpoints. Possible values: <code>"Higher"</code> (a higher value of each endpoint indicates a more favorable outcome) and <code>"Lower"</code> (a lower value of each endpoint indicates a more favorable outcome).  
</p>
</li>
<li> <p><code>n_comparisons</code>: Integer value defining the number of dose-control comparisons in the trial. This value must be positive.
</p>
</li>
<li> <p><code>n_endpoints</code>: Integer value defining the number of endpoints in the trial. This value must be positive. Either <code>n_comparisons</code> or <code>n_endpoints</code> must be greater than 1.
</p>
</li>
<li> <p><code>sample_size</code>: Integer vector defining the number of enrolled patients in each trial arm (control and experimental treatments). Each element must be positive.
</p>
</li>
<li> <p><code>control_mean</code>: Numeric vector defining the mean of each endpoint in the control arm. This parameter is required only with normally distributed endpoints (<code>endpoint_type="Normal"</code>).
</p>
</li>
<li> <p><code>control_sd</code>: Numeric vector defining the standard deviation of each endpoint in the control arm. Each element must be positive. This parameter is required only with normally distributed endpoints.
</p>
</li>
<li> <p><code>treatment_mean</code>: Numeric vector or matrix defining the mean of each endpoint in each experimental treatment arm. In clinical trials with several endpoints and several dose-placebo comparisons, the rows corresponds to the endpoints and the columns corresponds to the treatment-control comparisons. This parameter is required only with normally distributed endpoints.
</p>
</li>
<li> <p><code>treatment_sd</code>: Numeric vector or matrix defining the standard deviation of each endpoint in each experimental treatment arm. In clinical trials with several endpoints and several dose-placebo comparisons, the rows corresponds to the endpoints and the columns corresponds to the treatment-control comparisons. Each element must be positive. This parameter is required only with normally distributed endpoints.
</p>
</li>
<li> <p><code>control_rate</code>: Numeric vector defining the proportion or response rate for each endpoint in the control arm. Each element must be between 0 and 1. This parameter is required only with binary endpoints (<code>endpoint_type=</code> <code>"Binary"</code>).
</p>
</li>
<li> <p><code>treatment_rate</code>: Numeric vector or matrix defining the proportion or response rate for each endpoint in each experimental treatment arm. In clinical trials with several endpoints and several dose-placebo comparisons, the rows corresponds to the endpoints and the columns corresponds to the treatment-control comparisons. Each element must be between 0 and 1. This parameter is required only with binary endpoints.
</p>
</li>
<li> <p><code>endpoint_correlation</code>: Numeric matrix defining the pairwise correlations among the endpoint-specific test statistics. Each element must be between 0 and 1 and the matrix must be positive definite. This parameter is required only in trials with multiple endpoints.
</p>
</li>
<li> <p><code>mult_test</code>: Character value defining the multiple testing procedure, global testing procedure or gatekeeping procedure. Possible values:  
</p>

<ul>
<li> <p><code>"Bonferroni"</code>: Bonferroni multiple testing procedure.
</p>
</li>
<li> <p><code>"Holm"</code>: Holm multiple testing procedure in trials with a single source of multiplicity or Holm-based gatekeeping procedure in trials with several sources of multiplicity.
</p>
</li>
<li> <p><code>"Fixed-sequence"</code>: Fixed-sequence multiple testing procedure.
</p>
</li>
<li> <p><code>"Chain"</code>: Chain multiple testing procedure.
</p>
</li>
<li> <p><code>"Hochberg"</code>: Hochberg multiple testing procedure in trials with a single source of multiplicity or Hochberg-based gatekeeping procedure in trials with several sources of multiplicity.
</p>
</li>
<li> <p><code>"Hommel"</code>: Hommel multiple testing procedure in trials with a single source of multiplicity or Hommel-based gatekeeping procedure in trials with several sources of multiplicity.
</p>
</li>
<li> <p><code>"O'Brien"</code>: O'Brien global testing procedure.
</p>
</li>
</ul>
<p>Note that the O'Brien procedure can be used only in two-arm trials with several endpoints, similarly gatekeeping procedures can be used only in trials with several endpoints and several dose-placebo comparisons.

</p>
</li>
<li> <p><code>weights</code>: Numeric vector defining the initial hypothesis weights. Each element must be between 0 and 1. This parameter is required only with multiple testing procedures.
</p>
</li>
<li> <p><code>transition</code>: Numeric matrix defining the hypothesis transition parameters. Each element must be between 0 and 1 and the sum of elements in each row must be less than or equal to 1. This parameter is required only with the chain multiple testing procedure.
</p>
</li>
<li> <p><code>sequence</code>: Integer vector defining the hypothesis testing sequence. This parameter is required only with the fixed-sequence multiple testing procedures.
</p>
</li>
<li> <p><code>mult_method</code>: Character value defining the mixture method for the gatekeeping procedure. Possible values:  
</p>

<ul>
<li> <p><code>"Standard"</code>: Standard mixture method.
</p>
</li>
<li> <p><code>"Modified"</code>: Modified mixture method.
</p>
</li>
<li> <p><code>"Enhanced"</code>: Enhanced mixture method.
</p>
</li>
</ul>
<p>This parameter is required only with gatekeeping procedures.

</p>
</li>
<li> <p><code>mult_test_gamma</code>: Numeric vector defining the truncation parameter for each endpoint-specific family of hypotheses. The vector's length must be equal to the number of endpoints. Each element must be between 0 and 1, the last element may be equal to 1 whereas the other elements must be strictly less than 1. This parameter is required only with gatekeeping procedures.
</p>
</li>
<li> <p><code>dropout_rate</code>: Numeric value defining the patient dropout rate. A uniform patient dropout process is assumed and thus this parameter defines the fraction of patients that will be excluded from the analysis. This value must be between 0 and 1.
</p>
</li>
<li>
<p>alpha: Numeric value defining the overall one-sided Type I error rate. The default value is 0.025.
</p>
</li>
<li> <p><code>random_seed</code>: Integer value defining the random number generator seed. The default value is 49283.
</p>
</li>
<li> <p><code>nsims</code>: Integer value defining the number of simulation runs.
</p>
</li>
<li> <p><code>ncores</code>: Integer value defining the number of cores for parallel calculations. The number of cores cannot exceed the maximum available number of cores. The default value is 1. 
</p>
</li>
</ul>
</td>
</tr></table>
<h3>Value</h3>

<p>The function returns an object of class ‘<span class="samp">⁠MultAdjResults⁠</span>’. This object is a list with the following components:
</p>
<table>
<tr style="vertical-align: top;">
<td><code>parameters</code></td>
<td>
<p>List containing the user-specified parameters.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>sim_results</code></td>
<td>
<p>Data frame containing the raw and adjusted p-values generated by the hypothesis tests for each simulation run. The first set of n columns correspond to the raw p-values for the n null hypotheses and the next set of n columns correspond to the adjusted p-values for the n null hypotheses.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>sim_summary</code></td>
<td>
<p>List containing the power calculation results for the specified multiple testing procedure, global testing procedure or gatekeeping procedure.</p>
</td>
</tr>
</table>
<p>A detailed summary of the simulation results can be created using the <code>GenerateReport</code> function.
</p>


<h3>See Also</h3>

<p><code>MultAdjApp</code>, <code>MultAdjExample1</code>, <code>MultAdjExample2</code>, <code>MultAdjExample3</code>
</p>


</div>